Chemistry Letters 2001
301
48, 233 (1999).
sistent with the facial coordination of the PCN/CH3 ligand. The
1H and 31P NMR indicated that fac-4 was gradually converted fur-
ther to minor-4, which can be tentatively assigned to a geometrical
isomer mer-4.11 After 17 days at 50 °C mer-4 became the major
isomer (fac-4 : mer-4 = 10 : 90). From the stereochemical consid-
eration, fac-4 and mer-4 were exclusively derived from the isomer
3a. We could not obtain the concrete evidence that the C–H bond
activation of the diastereomer 3b proceeded under these condi-
tions.
3
a) M. Yabuta, S. Nakamura, T. Yamagata, and K. Tani, Chem. Lett.,
1993, 323. b) K. Tani, M. Yabuta, S. Nakamura, and T. Yamagata, J.
Chem. Soc., Dalton Trans., 1993, 2781. c) K. Tani, S. Nakamura, T.
Yamagata, and Y. Kataoka, Inorg. Chem., 32, 5398 (1993). d) Y.
Kataoka, Y. Tsuji, O. Matsumoto, T. Ohashi, T. Yamagata, and K. Tani,
J. Chem. Soc., Chem. Commun., 1995, 2099.
4
5
Y. Kataoka, Y. Imanishi, T. Yamagata, and K. Tani, Organometallics,
18, 3563 (1999).
The PN/CH3 ligand could be prepared by a similar method to that of the
PNn=1 ligand from 1-(o-diphenylphosphinophenyl)ethanol and 2-picolyl
chloride. 2 (racemic compound): 1H NMR (CDCl3, 30 °C) δ 1.37 (d, J
= 6.3 Hz, 3H), 4.35 (d, J = 13.2 Hz, 1H), 4.43 (d, J = 13.2 Hz, 1H),
5.36–5.50 (m, 1H), 6.86–6.98 (m, 1H), 7.10–7.46 (m, 14H), 7.58–7.72
(m, 2H), 8.46–8.56 (m, 1H). 31P{1H}NMR (CDCl3, 30 °C) δ –17.0 (s).
Anal. (C26H24ONP) C, H, N.
6
3: Mp 183.0 °C (dec.). Both 3-major and 3-minor showed very similar
sets of 1H NMR which can well explain structures 3a or 3b, respective-
ly. Some representative NMR data: 1H NMR (CD2Cl2, 30 °C) 3-major
δ 1.56 (d, J = 7.0 Hz, 3H, –CHMeO–), 5.02–5.20 (m, 1H, –CHMe–),
5.10 (d, J = 14.1 Hz, 1H, –OCH2–py), 5.53 (d, J = 14.1 Hz, 1H,
–OCH2–py); 3-minor 2.38 (d, J = 6.6 Hz, 3H, –CHMeO–), 5.02–5.20
(m, 1H, –CHMe–), 4.68 (d, J = 15.5 Hz, 1H, –OCH2–py), 5.26 (d, J =
15.5 Hz, 1H, –OCH2–py). 31P{1H}NMR (CD2Cl2, 30 °C) δ 5.37 (s,
major), 7.46 (s, minor). Anal. Found: C, 48.12; H, 4.35; N, 1.75%.
Calcd for C34H36F6IrNOP2: C, 48.45; H, 4.31; N, 1.66%.
7
Crystal data for 3a: C34H36F6IrNOP2, fw = 842.78, Rigaku AFC7R, tri-
–
clinic, P1 (No. 2), a = 11.259(8), b = 14.618(9), c = 9.926(10) Å, α =
95.39(7), β = 89.97(9), γ = 95.60(5) ˚, V = 1619(2) Å3, Z = 2, T = 296(2)
K, Dcalcd = 1.729 Mg m–3, λ = 0.71069 Å, F(000) = 832, µ = 4.287
mm–1, Tmin = 0.2789, Tmax = 0.6057, 2θ(max) = 60 deg, 19598 measured
reflections, 9417 unique reflections, Rint = 0.0302, solution method
SIR97, refinement method SHELXL97, R(all data) = 0.0418, wR(all) =
0.0789, R(I > 2σ(I)) = 0.0279, wR(I > 2σ(I)) = 0.0737, GOF = 1.052,
∆/σ(max) = 0.001.
8
9
The 1H NMR of complex 3 in the presence of additional free COD (ca.
10 equiv) in CD3CN at 30 °C afforded the same broad signals besides
the signals of the added free COD.
fac-4: mp 78.0 °C (dec.). 1H NMR (CD3CN, 30 °C) δ –20.72 (d, J =
22.7 Hz, 1H), 1.78–2.14 (br, 6H), 2.09 (s, 3H), 3.64 (d, J = 15.8 Hz,
1H), 4.09 (d, J = 15.8 Hz, 1H), 6.78–7.98 (m, 17H), 8.64 (d, J = 5.5 Hz,
1H). 31P{1H}NMR (CD3CN, 30 °C) δ 27.4 (s), –143.2 (septet, J = 706
Hz, PF6). MS (FAB) m/z 590 (M+–PF6–2CH3CN). IR (nujol) 2280,
2178, 1606, 1111, 850, 838, 770, 750, 724 and 697 cm-1. Anal. Found:
C, 43.76; H, 3.44; N, 5.06%. Calcd for C30H30F6IrN3OP2: C, 44.12; H,
1
The H NMR of complex 3 in the presence of CH3CN (ca.
3.70; N, 5.14%. Crystal data: C30H30F6IrN3OP2, fw = 842.78, Rigaku
–
1.7 equiv) in CD2Cl2 indicated a new signal at δ 1.99 due to the Ir-
coordinated CH3CN of an intermediate complex in addition to the
signals of complex 3 and free CH3CN (δ 1.98), but did not show
any signals for free-COD. After 5 days at room temperature (ca.
20 °C), the C–H bond activation products 4 appeared (major-3 :
minor-3 : fac-4 : mer-4 = 48 : 26 : 20 : 6). The C–H bond activa-
tion, however, did not proceed at all in the absence of CH3CN
under the same conditions. Complex 3 was stable in a mixed sol-
vent of CD2Cl2 and CD3OD and deuterium incorporation into
complex 3 could not be detected; a plausible reversible C–H bond
activation did not occur in these solvent systems. The hypothesis
that dissociation of COD from complex 3 is the driving force for
this C–H bond activation is inconsistent with the fact that the rate
of the C–H bond activation in CD3CN was not affected by the
presence of excess COD. Coordination of CH3CN renders the
metal center more electron rich, which causes facile C–H bond
activation in only complex 3a.12
RAXIS-RAPID, triclinic, P1 (No. 2), a = 11.7843(4), b = 14.5811(6), c
= 9.4638(4) Å, α = 105.4882(14), β = 96.9441(15), γ = 97.2193(14) ˚, V
= 1534.25(10) Å3, Z = 2, T = 100(1) K, Dcalcd = 1.768 Mg m–3, λ =
0.71069 Å, F(000) = 800, µ = 4.521 mm–1, Tmin = 0.4592, Tmax
=
0.6958, 2θ(max) = 63 deg, 29369 measured reflections, 10149 unique
reflections, Rint = 0.0745, solution method SIR97, refinement method
SHELXL97, R(all data) = 0.0793, wR(all) = 0.0952, R(I > 2σ(I)) =
0.0488, wR(I > 2σ(I)) = 0.0871, GOF = 1.020, ∆/σ(max) = 0.000.
10 The PCN/CH3 ligand represents the PN/CH3 ligand acted as a P-C-N tri-
dentate ligand.
11 Although isolation of pure mer-4 has not been successful yet due to its
instability, the structure of mer-4 is determined by both the characteristic
shape of the 1H NMR signal for the proton at the 6-position of the pyri-
dine ring3 and the NOESY experiments. The proton at the 6-position of
the pyridine ring in mer-4 showed NOE only to the proton at the 5-posi-
tion of the pyridine ring, while that in fac-4 showed NOE to one of the
aromatic protons except the pyridine protons, in addition to the proton at
the 5-position of the pyridine ring. The relative positions of the hydrido
ligand and the two CH3CN ligands are also determined by NOESY
experiments. The Ir-H in mer-4 showed NOE to one of the α-methylene
protons of the pyridine ring, but not to the methyl group of the PN/CH3
ligand, while the Ir–H in fac-4 showed NOE to the methyl group, but
not to the α-methylene protons. 1H NMR of mer-4 (CD3CN, 30 °C) δ
–21.47 (d, J = 19.2 Hz, 1H), 1.10 (s, 3H), 1.78–2.14 (br, 6H), 4.66 (d, J
= 20.6 Hz, 1H), 4.71 (d, J = 20.8 Hz, 1H), 6.92–8.12 (m, 17H),
9.08–9.18 (m, 1H). 31P{1H}NMR (CD3CN, 30 °C) δ 21.4 (s), –143.2
(septet, J = 706 Hz, PF6).
This work was supported by a Grant-in-Aid for Scientific
Research from the Ministry of Education, Science, Sports, and
Culture, Japan.
12 The accelerating effect by the coordination of CH3CN to the metal cen-
ter was also observed in the reaction of [Ir(cod)(PN)]PF6. For example,
C–H activation of [Ir(cod)(PN)]PF6 in CH3CN was almost completed at
50 °C for 3 h, while the C–H activation in CDCl3 proceeded only ca.
20% under the same conditions.
References and Notes
1
J. Seyden-Penne, “Chiral Auxiliaries and Ligands in Asymmetric
Synthesis,” John Wiley & Sons, New York (1995).
C. S. Slone, D. A. Weinberger, and C. A. Mirkin, Prog. Inorg. Chem.,
2